5Lopez-Ibor-JJ Jr, Saiz J, Cottraux J, et al. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. Eur Neuropsychopharmacol, 1996.6 : 111.
6Browne M, Horn E, Jones TT. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder. Can J Psychiatry, 1993,38:242.
7Ravizza L, Barzega G, Bellino S, et al. Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry, 1995,56:368.
8Ackerman DL, Greenland S, Bystritsky A. Clinical characteristics of response to fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol, 1998,18 : 185.
9Romanno S,Goodman W,Tamura R,et al. Long-term treatment of obsessive-compulsive disorder after an acute response : a comparison of fluoxetine versus placebo. J Clin Psychopharmacol, 2001,21:46.
10Tollefson GD, Birkett M, Koran L, et al. Continuation treatment of OCD :double-bllnd and open-label experince with fluoxetine. J Clin Psychiatry,1994,55(suppl) :69.
7Martindale the Extra Pharmacopoeia[M].34th ed.London:RoyalPharmaceutical Society,2005:289-291.
8Liston HL,DeVane CL,Boulton DW,et al.Differential time courseof cytochrome P450 2D6 enzymeinhibition byfluoxetine,sertraline,andparoxetine in healthy volunteers[J].J Clin Psychopharmacol,2002,,22:169-173.
9US FOOD AND DRUG ADMINISTRATION.FDA Public Health Advisory.Suicidality in children and adolescents being treated with antidepressantmedications[EB/OL].[2004—10—15].http://www.fda.gov/cder/dru g/antidepressants/SSRIPHA200410.Htm.
